Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
41S RIO GRANDE STREET, SALT LAKE CITY, UT
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
15 Oct 2026

Recursion Pharmaceuticals, Inc. reported A material agreement

Recursion Pharmaceuticals, Inc. filed an 8-K covering a material agreement, operating or financial results, Regulation FD disclosure, another company event, supporting financial statements or exhibits.

21 Sep 2026

Recursion Pharmaceuticals, Inc. reported A material agreement

Recursion Pharmaceuticals, Inc. filed an 8-K covering a material agreement.

7 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Recursion Pharmaceuticals, Inc..

5 Aug 2026

Recursion Pharmaceuticals, Inc. filed Form 10-Q

Recursion Pharmaceuticals, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

5 Aug 2026

Recursion Pharmaceuticals, Inc. reported Operating or financial results

Recursion Pharmaceuticals, Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$545.68M
Total assets (USD)$1.21B
Total liabilities (USD)$297.67M
Shareholders' equity (USD)$915.00M
Long-term debt (USD)$723,000

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q2 2026$7.67M−$134.97M−$131.01M−$0.2510-Q · 5 Aug 2026
Q1 2026$6.47M−$128.51M−$117.50M−$0.2210-Q · 6 May 2026
Q4 2025$35.54M−$108.33M−$108.12MUnavailable10-K · 25 Feb 2026
Q3 2025$5.18M−$172.20M−$162.25M−$0.3610-Q · 5 Nov 2025
Q2 2025$19.22M−$176.23M−$171.90M−$0.4110-Q · 5 Aug 2025
Q1 2025$14.75M−$191.37M−$202.49M−$0.5010-Q · 5 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $6.63
83.7% upside potential
📈
Strong Buy
Unavailable
👍
Buy
2
⏸️
Hold
3
📉
Sell
0
5 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 5.90–8.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
6
Oct 2026
Borgeson Blake
Director
Open-market sale
$4.84 per share
50,000 shares
SEC Form 4
6
Oct 2026
HERSHBERG ROBERT
Director
Option exercise
$2.22 per share
25,000 shares
SEC Form 4
6
Oct 2026
HERSHBERG ROBERT
Director
Open-market sale
$5.00 per share
25,000 shares
SEC Form 4
1
Oct 2026
Dar Zavain
Director
Grant or award
Unavailable per share
4,607 shares
SEC Form 4
1
Oct 2026
Li Dean Y
Director
Grant or award
Unavailable per share
3,378 shares
SEC Form 4
15
Sep 2026
Taylor Ben R
Chief Financial Officer
Tax withholding
$3.41 per share
5,396 shares
SEC Form 4
8
Sep 2026
Khan Najat
Director, CEO and President
Open-market sale
$3.52 per share
22,408 shares
SEC Form 4
1
Sep 2026
Borgeson Blake
Director
Open-market sale
$3.34 per share
30,000 shares
SEC Form 4
17
Aug 2026
Khan Najat
Director, CEO and President
Tax withholding
$3.16 per share
80,498 shares
SEC Form 4

Top Shareholders

Blackrock, Inc.
50,304,691 shares
16.467% change
6/30/2026
Vanguard Group Inc
47,187,759 shares
18.621% change
12/31/2025
Ark Investment Management Llc
41,337,632 shares
2.797% change
6/30/2026
State Street Corp
34,706,130 shares
21.816% change
6/30/2026
Vanguard Portfolio Management Llc
31,131,599 shares
36.787% change
6/30/2026
Baillie Gifford & Co
23,487,907 shares
-0.792% change
6/30/2026
Vanguard Capital Management Llc
22,765,940 shares
2.345% change
6/30/2026
Geode Capital Management, Llc
13,819,135 shares
12.579% change
6/30/2026
Softbank Group Corp.
13,636,515 shares
0% change
6/30/2026
Mic Capital Management Uk Llp
9,644,033 shares
0% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago